Research - ProBCI
The Erasmus MC study focuses on patients with non‑muscle‑invasive bladder cancer, who are at high risk of progressing to muscle‑invasive bladder cancer.
Research based on data and materials within ProBCI can be initiated and executed by participating centres and external research groups. Studies include non‑muscle‑invasive bladder cancer, bladder cancer, and urothelial carcinoma in various settings. Publications cover outcomes and real‑world treatment patterns for metastatic bladder cancer.
Identification of molecular mechanisms that allow bladder tumors to grow despite BCG treatment could enable better prediction of BCG response, improving treatment efficiency and reducing unnecessary burden on patients.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.